CTRI/2023/09/057950尚未招募Unknown
A Randomized Control Double Blind Parallel group without Placebo Clinical Trial to look the antropometric outcome of Vitamin B12 supplementation in children with severe acute malnutrition(SAM) aged b1 month to 60 months in Nutritional Rehabilitation Center - NI
Moti Lal Nehru Medical College Allahabad0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Parents or guardians willing to give written informed consent
- •2.Age group of 1 month to 60 month children with severe acute malnutrition(SAM)
- •3.SAM will be defined as : Mid upper arm circumference (MUAC) <11.5 cm and/or weight for height/length <-3 standard deviation and/or bilateral pitting edema
排除标准
- •1. All children with non-nutritional anaemia (malignancy,haemolytic anaemia and aplastic anaemia)
- •2. Children diagnosed to have chronic liver disease, chronic kidney disease, GIT disorder(inflammatory bowel disorders),heart disease,infantile tremor syndrome
- •3. Children with unstable viatals
研究者
相似试验
尚未招募
不适用
A clinical based study to find out the exact lowest possible dose of ketamine, a drug which takes care of the pain and also helps in maintaining the state of anaesthesia during surgery, in keeping the patient pain free in the period after Laparoscopic Cholecystectomy surgery.CTRI/2020/01/022983Midnapore Medical College
已完成
3 期
CLINICAL TRIAL OF IN-AQUL-001 TO TREAT PRIMARY INSOMNIA IN ADULT & ELDERLY PATIENTSCTRI/2010/091/001443Intas Pharmaceuticals Limited280
已完成
不适用
Effects of medical qigong for human body in short and medium termJPRN-UMIN000046305Ebisu Plastic Surgery / Beauty Clinic30
进行中（未招募）
1 期
AN EQUIVALENCE TRIAL TO COMPARE THE EFFICACY, SAFETY, PHARMACOKINETICS AND IMMUNOGENICITY OF HD204 TO AVASTIN® IN PATIENTS WITH LUNG CANCER.on-squamous Non-small Cell Lung Cancer (nsNSCLC)MedDRA version: 20.0Level: LLTClassification code 10079440Term: Non-squamous non-small cell lung cancerSystem Organ Class: 100000004864EUCTR2017-005175-78-LVPrestige BioPharma Limited592
进行中（未招募）
1 期
AN EQUIVALENCE TRIAL TO COMPARE THE EFFICACY, SAFETY, PHARMACOKINETICS AND IMMUNOGENICITY OF HD204 TO AVASTIN® IN PATIENTS WITH LUNG CANCER.EUCTR2017-005175-78-HUPrestige BioPharma Pte Ltd592